To prove our hypothesis, an in vitro study was performed using EGFR inhibitor, IGF-1R inhibitor, and miRNA mimics in two Gefitinib-resistant NSCLC cell lines, NCI-H1975 with a secondary T790M mutation in EGFR, and NCI-H460. The gene discussed is IGF1R; the disease is non-small cell lung carcinoma.